Prognostic Analysis of 1091 Cases of Lung Cancer
Han Xiang-w
Abstract
Han Xiang-w
Abstract
Objective To explore the prognostic factors of lung cancer.Methods 1 091 cases of primary lung cancer were analysed in age、clinical stage、pathology and therapy.Product-limit method was used to calculate the survival rate,its significance was tested by logrank test.Results The overall 1、3、5 year survival rate was 29.6%、9.4%、5.0% respectively.The 5-year survival rate of 40~50 years old patients was higher than those of others(P0.05).The 5-year survival rate was 13.2% for squamous carcinoma, 9.5% for adenocarcinoma,0 for small cell carcinoma(P0.05).The 5-year survival rate was 17.0% in stage Ⅰ,9.5% in stage Ⅱ,1.9% in stage Ⅲa,0 in stage Ⅲb and Ⅳ(P0.05).The 5-year survival rate was 18.1% in treatment with operation,0.02%,without operation.The 5-year survival rate was 25.7% in lobectomy and 10.8% in pneumonectomy(P0.05).The 5-year survival rate for surgery alone(22.1%) was higher than those for operation plus radiotherapy and/or chemotherapy,but there was not significant difference(P0.05).The 5-year survival rate was 2.4% for radiotherapy and chemotherapy group and 0 for other treatment without operation(P0.05).Conclusion Age、pathology、clinical stage and different treatment were important factors affecting prognosis of lung cancer.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To explore the prognostic factors of lung cancer.Methods 1 091 cases of primary lung cancer were analysed in age、clinical stage、pathology and therapy.Product-limit method was used to calculate the survival rate,its significance was tested by logrank test.Results The overall 1、3、5 year survival rate was 29.6%、9.4%、5.0% respectively.The 5-year survival rate of 40~50 years old patients was higher than those of others(P0.05).The 5-year survival rate was 13.2% for squamous carcinoma, 9.5% for adenocarcinoma,0 for small cell carcinoma(P0.05).The 5-year survival rate was 17.0% in stage Ⅰ,9.5% in stage Ⅱ,1.9% in stage Ⅲa,0 in stage Ⅲb and Ⅳ(P0.05).The 5-year survival rate was 18.1% in treatment with operation,0.02%,without operation.The 5-year survival rate was 25.7% in lobectomy and 10.8% in pneumonectomy(P0.05).The 5-year survival rate for surgery alone(22.1%) was higher than those for operation plus radiotherapy and/or chemotherapy,but there was not significant difference(P0.05).The 5-year survival rate was 2.4% for radiotherapy and chemotherapy group and 0 for other treatment without operation(P0.05).Conclusion Age、pathology、clinical stage and different treatment were important factors affecting prognosis of lung cancer.
Key concepts: Medicine, Lung cancer, Survival rate, Stage (stratigraphy), Radiation therapy, Adenocarcinoma, Pneumonectomy, Internal medicine